Novo Holdings Leads $50M Series F Extension in Route 92 Medical
September 23, 2024
Novo Holdings led a $50 million investment in Route 92 Medical as a Series F extension, joining returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group. The financing will accelerate global commercialization of Route 92's neurovascular intervention product portfolio and support regulatory authorizations in new geographies; Novo Holdings' Noel Jee will join Route 92's board.
- Buyers
- Novo Holdings, U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, The Vertical Group
- Targets
- Route 92 Medical
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Novo Holdings Leads $50M Growth Investment in MedGenome
August 30, 2022
Biotechnology
Novo Holdings led a $50 million minority investment in MedGenome alongside existing investors LeapFrog Investments and Sofina. The capital will support MedGenome’s expansion beyond South Asia into Africa and the Middle East and broaden access to its genomic testing, bioinformatics and research services.
-
Medix Infusion Raises $35M Series B Led by Echo Health Ventures and Acquires Infusion Operations of the Center for Neurology and Spine
January 9, 2023
Healthcare Services
Medix Infusion closed a $35 million Series B led by Echo Health Ventures with participation from Pittco Direct Investments II and Noro-Moseley Partners, and simultaneously secured a debt facility with Live Oak Bank. Medix will use the capital to support organic growth and to acquire the infusion operations of the Center for Neurology and Spine, expanding its ambulatory infusion footprint into Arizona.
-
Novo Holdings Invests £50m in Oxford Nanopore Technologies
August 1, 2024
Biotechnology
Novo Holdings has invested £50 million in UK-listed Oxford Nanopore Technologies via an equity issue and intends to make further share purchases in the secondary market. The investment is intended to support Oxford Nanopore's commercial growth and capability expansion in biopharmaceutical and biomanufacturing markets.
-
Novo Holdings Acquires Medical Knowledge Group
January 3, 2022
Healthcare Services
Novo Holdings A/S has agreed to acquire Medical Knowledge Group (MKG) from Court Square Capital and Aisling Capital. MKG is an analytics-driven, technology-enabled drug commercialisation and medical communications platform headquartered in New York with more than 500 employees; Novo said the acquisition will support MKG's continued growth in biopharmaceutical commercialisation services.
-
Novo Holdings Invests in Manipal Hospitals
February 6, 2024
Healthcare Services
Novo Holdings has made an investment in Manipal Hospitals, a leading private hospital chain in India — Novo Holdings' largest investment in Asia to date. Manipal operates a network of hospitals (33 sites, ~9,500+ beds) and a large medical staff (5,000+ doctors), and the investment is intended to support Manipal's next phase of growth and expansion of high-quality, affordable healthcare across India.
-
Water Street Healthcare Partners Backs Renovo Solutions with Growth Investment
January 11, 2022
Healthcare Services
Renovo Solutions received a growth investment from Water Street Healthcare Partners to accelerate expansion of its healthcare and life sciences equipment management services. The investment will fund enhancements to Renovo's proprietary equipment-management system, geographic expansion beyond its current 37+ states, and the recruitment of Bill Newell as CEO to lead growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.